What the Research Says About LDN and Weight
- There is no clinical trial proving that LDN alone causes weight loss.
- Some small observational studies and case reports suggest potential benefits for:
- Reducing reward-driven eating patterns*
- Supporting behavior consistency*
- Enhancing motivation for lifestyle adherence*
These mechanisms may support efforts related to weight management, particularly when emotional or habitual patterns are a factor. However, controlled research is still needed.
In FDA-approved Contrave®, naltrexone is combined with bupropion. However, the clinical effects cannot be attributed to LDN alone.
Greenway et al., 2010 – The Lancet
Eden’s Approach to LDN: Everyday+ Weight
Licensed providers working with Eden may recommend LDN as part of a provider-directed care strategy to support behavioral or emotional wellness.
These blends may support:
- Awareness of emotional or habitual eating
- Appetite stabilization during medication transitions
- Motivation and mood regulation*
Other active ingredients may include:
- Inositol
- Acetyl-L-carnitine
- Vitamins B6 and B12
Optional additions (per provider discretion): acarbose, orlistat
*These uses are not FDA-approved. Medications are prescribed at the discretion of licensed providers based on individual clinical assessment.
Q: Will LDN make me lose weight?
A: LDN is not a weight loss drug and is not FDA-approved for that purpose. However, for some people, it may help address underlying behavioral patterns that contribute to weight challenges. Eden providers focus on mood and habit support, not guaranteed weight outcomes.
What Eden Users Say
While formal clinical studies are ongoing, Eden members have reported:
- “I wasn’t obsessing over snacks like I used to.”
- “It helped me follow through on routines without overthinking.”
- “I felt more emotionally level, especially during the day.”
Possible early side effects:
- Mild nausea or vivid dreams (usually within the first 1–2 weeks)
- Sleep changes (dose timing may help mitigate this)
Disclaimer
Low-dose naltrexone is not FDA-approved for weight loss, cravings, or appetite control. Eden offers LDN in off-label, provider-directed compounded formulations. Any outcomes mentioned are based on small-scale observations and individual reports—not guaranteed or FDA-validated. Eden does not manufacture or dispense medications; all prescriptions are filled by third-party, state-licensed compounding pharmacies.
Curious if low-dose naltrexone could support your behavior reset?
Take Eden’s free provider-guided assessment to explore if you're a candidate for care plans that may support behavior change, motivation, or appetite awareness.